1. Home
  2. KLTO vs HOND Comparison

KLTO vs HOND Comparison

Compare KLTO & HOND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLTO
  • HOND
  • Stock Information
  • Founded
  • KLTO 2019
  • HOND 2024
  • Country
  • KLTO United States
  • HOND United States
  • Employees
  • KLTO N/A
  • HOND N/A
  • Industry
  • KLTO
  • HOND
  • Sector
  • KLTO
  • HOND
  • Exchange
  • KLTO NYSE
  • HOND NYSE
  • Market Cap
  • KLTO 5.9M
  • HOND 334.9M
  • IPO Year
  • KLTO N/A
  • HOND 2024
  • Fundamental
  • Price
  • KLTO $1.00
  • HOND $11.19
  • Analyst Decision
  • KLTO
  • HOND
  • Analyst Count
  • KLTO 0
  • HOND 0
  • Target Price
  • KLTO N/A
  • HOND N/A
  • AVG Volume (30 Days)
  • KLTO 91.0M
  • HOND 542.2K
  • Earning Date
  • KLTO 08-15-2025
  • HOND 01-01-0001
  • Dividend Yield
  • KLTO N/A
  • HOND N/A
  • EPS Growth
  • KLTO N/A
  • HOND N/A
  • EPS
  • KLTO N/A
  • HOND 0.20
  • Revenue
  • KLTO N/A
  • HOND N/A
  • Revenue This Year
  • KLTO N/A
  • HOND N/A
  • Revenue Next Year
  • KLTO N/A
  • HOND N/A
  • P/E Ratio
  • KLTO N/A
  • HOND $54.72
  • Revenue Growth
  • KLTO N/A
  • HOND N/A
  • 52 Week Low
  • KLTO $0.11
  • HOND $9.90
  • 52 Week High
  • KLTO $3.91
  • HOND $12.24
  • Technical
  • Relative Strength Index (RSI)
  • KLTO N/A
  • HOND N/A
  • Support Level
  • KLTO N/A
  • HOND N/A
  • Resistance Level
  • KLTO N/A
  • HOND N/A
  • Average True Range (ATR)
  • KLTO 0.00
  • HOND 0.00
  • MACD
  • KLTO 0.00
  • HOND 0.00
  • Stochastic Oscillator
  • KLTO 0.00
  • HOND 0.00

About KLTO KLOTHO NEUROSCIENCES INC

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

About HOND HCM II ACQUISITION CORP

HCM II Acquisition Corp is a blank check company.

Share on Social Networks: